5news.U.S. news, all in one place

BREAKING

› Bidets save you money and reduce waste — we tested the best options out there › 50+ products to make your life easier and our planet cleaner › Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love › A head-to-toe guide of how men should dress this spring, and where they should shop › 42 of the most useful travel products you can buy on Amazon › The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension › Composting is an easy way to reduce food waste. Here's how to do it › We stopped using aluminum foil for cooking and you should too. Here's what to use instead › The beloved Dyson Supersonic hair dryer is at its lowest price ever › Bidets save you money and reduce waste — we tested the best options out there › 50+ products to make your life easier and our planet cleaner › Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love › A head-to-toe guide of how men should dress this spring, and where they should shop › 42 of the most useful travel products you can buy on Amazon › The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension › Composting is an easy way to reduce food waste. Here's how to do it › We stopped using aluminum foil for cooking and you should too. Here's what to use instead › The beloved Dyson Supersonic hair dryer is at its lowest price ever

Business

‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks

MarketWatch · October 13, 2026 at 11:37 AM

‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks

The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.

Read the full article on MarketWatch ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.marketwatch.com — the content belongs to MarketWatch.

More from MarketWatch

New SEC rules would fleece everyday investors to enrich Wall Street

MarketWatch · 18 min ago

‘I am a pretty cautious person’: My financial adviser wants me to invest $350,000 in a UAE data center. Is this risky?

MarketWatch · 42 min ago

My wife says we can’t afford to retire, yet she wants to take an $8,000 trip to Italy. We have $4 million. Do I keep working?

MarketWatch · 42 min ago

How to read your body’s warning signs years before you get sick

MarketWatch · 50 min ago

More in Business

Being chronically online is part of the job description for this top influencer marketer

Business Insider · 4 min ago

Kimberly Guilfoyle resigns as ambassador to Greece at White House's request

CNBC · 5 min ago

Stocks fall after bank earnings deluge; chipmakers slide: Live updates

CNBC · 12 min ago

Ukraine isn't focused only on making drones and missiles — it's also prioritizing the jet engines inside

Business Insider · 13 min ago

New SEC rules would fleece everyday investors to enrich Wall Street

MarketWatch · 18 min ago

The White House is in its Trump-fueled SI era

Business Insider · 19 min ago